Trang chủ »Y Tế - Sức Khoẻ »

Y khoa - Dược

8 trang

6 lượt xem

2

0

Evaluating the result of cytoreductive surgery after neoadjuvant chemotherapy in advanced epithelial ovarian cancer

A retrospective study of 61 patients was conducted to evaluate the preliminary results of maximal cytoreductive surgery following neoadjuvant chemotherapy for FIGO stage IIIC-IV ovarian cancer from 2019 to 2023.

viyamanaka

06/02/2025

Ovarian cancer

Maximal cytoreductive surgery

Neoadjuvant chemotherapy

Primary maximal cytoreductive surgery

Adjuvant chemotherapy

/

8

Có thể bạn quan tâm

Clinical utility of R-OPS score in the preoperative diagnosis of ovarian cancer: A prospective cohort study

Clinical utility of R-OPS score in the preoperative diagnosis of ovarian cancer: A prospective cohort study

Single agent topotecan in platinum resistant recurrent ovarian cancer: A study in Viet Nam National Cancer hospital

Single agent topotecan in platinum resistant recurrent ovarian cancer: A study in Viet Nam National Cancer hospital

Developing the ‘OCRAT’ Progressive Web Application (PWAs) for assessing ovarian cancer risk strategies

Developing the ‘OCRAT’ Progressive Web Application (PWAs) for assessing ovarian cancer risk strategies

Developing the ‘OCRAT’ Progressive Web Application (PWAs) for assessing ovarian cancer risk strategies

Developing the ‘OCRAT’ Progressive Web Application (PWAs) for assessing ovarian cancer risk strategies

Summary of medical doctoral thesis: Research on the value of tumor marker CA125 and HE4 in diagnosis stage and treatment ovarian cancer

Summary of medical doctoral thesis: Research on the value of tumor marker CA125 and HE4 in diagnosis stage and treatment ovarian cancer

Báo cáo khoa học: Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview

Báo cáo khoa học: Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview

Báo cáo khoa học: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-jB1

Báo cáo khoa học: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-jB1

Báo cáo khoa học: BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications

Báo cáo khoa học: BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications

Báo cáo khoa học: Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells – analysis of the molecular mechanisms of its antiproliferative action

Báo cáo khoa học: Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells – analysis of the molecular mechanisms of its antiproliferative action

báo cáo hóa học:" Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature"

báo cáo hóa học:" Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature"

báo cáo hóa học:" Gene Expression and Pathway Analysis of Ovarian Cancer Cells Selected for Resistance to Cisplatin, Paclitaxel, or Doxorubicin"

báo cáo hóa học:" Gene Expression and Pathway Analysis of Ovarian Cancer Cells Selected for Resistance to Cisplatin, Paclitaxel, or Doxorubicin"

báo cáo hóa học:" Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells"

báo cáo hóa học:" Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells"

báo cáo hóa học:" Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer"

báo cáo hóa học:" Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer"

báo cáo hóa học:" The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles"

báo cáo hóa học:" The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles"

báo cáo hóa học:" KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells"

báo cáo hóa học:" KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells"

báo cáo hóa học:" Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences"

báo cáo hóa học:" Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences"

Báo cáo y học: " Intraparenchymal metastases to the spleen from ovarian cancer: a case report"

Báo cáo y học: " Intraparenchymal metastases to the spleen from ovarian cancer: a case report"

báo cáo khoa học: "Primary malignant mixed Müllerian tumor arising from the mesorectum with a synchronous ovarian cancer: a case report and review of the literature"

báo cáo khoa học: "Primary malignant mixed Müllerian tumor arising from the mesorectum with a synchronous ovarian cancer: a case report and review of the literature"

Báo cáo y học: "Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report"

Báo cáo y học: "Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report"

báo cáo khoa học: "Ovarian cancer immunotherapy: opportunities, progresses and challenges"

báo cáo khoa học: "Ovarian cancer immunotherapy: opportunities, progresses and challenges"

Giới thiệu

Về chúng tôi

Việc làm

Quảng cáo

Liên hệ

Chính sách

Thoả thuận sử dụng

Chính sách bảo mật

Chính sách hoàn tiền

DMCA

Hỗ trợ

Hướng dẫn sử dụng

Đăng ký tài khoản VIP

Zalo/Tel:

093 303 0098

Email:

support@tailieu.vn

Phương thức thanh toán

Theo dõi chúng tôi

Facebook

Youtube

TikTok

Chịu trách nhiệm nội dung: Nguyễn Công Hà. ©2025 Công ty TNHH Tài Liệu trực tuyến Vi Na.

Địa chỉ: 54A Nơ Trang Long, P. Bình Thạnh, TP.HCM - Điện thoại: 0283 5102 888 - Email: info@tailieu.vn

Giấy phép Mạng Xã Hội số: 670/GP-BTTTT cấp ngày 30/11/2015